Myrto completed her Bachelor’s degree in Biochemistry and Biotechnology and a Master’s in Molecular Biology and Diagnostic Markers in Greece. She then moved to Luxembourg to pursue a PhD focused on rare pediatric neurometabolic disorders, where she employed zebrafish and induced pluripotent stem cell (iPSC) models to investigate disease mechanisms. Following her PhD, she spent approximately 1.5 years in industry as a postdoctoral researcher, developing iPSC-derived neuronal models to study neurodegenerative diseases and utilize them in immunocytochemistry-based drug screening assays.

Currently, as a postdoctoral researcher at MERLIN, she aims to use patient-derived iPSC midbrain organoids to model schizophrenia. Her project focuses on developing functional and molecular readouts for testing existing therapeutic agents, with the broader goal of assessing the potential of midbrain organoids as translational tools in therapeutic research for mental disorders.